Amyotrophic lateral sclerosis/motor neuron disease

Gene: CHMP2B

Red List (low evidence)

CHMP2B (charged multivesicular body protein 2B)
EnsemblGeneIds (GRCh38): ENSG00000083937
EnsemblGeneIds (GRCh37): ENSG00000083937
OMIM: 609512, Gene2Phenotype
CHMP2B is in 7 panels

2 reviews

Ellen McDonagh (Genomics England Curator)

Comment on list classification: Kept as red due to expert review. Not present on the NHNN NGS gene panel for ALS, and only found in one source under the ALS phenotype.
Created: 15 Jun 2016, 1:44 p.m.

Nayana Lahiri (South London GMC)

Red List (low evidence)

Defects in CHMP2B were originally reported in autosomal dominant FTD. The G>C single nucleotide change in the acceptor splice site of exon 6 of CHMP2B affected mRNA splicing, resulting in two aberrant transcripts: inclusion of the 201-bp intronic sequence between exons 5 and 6, or a short deletion of 10bp from the 5′ end of exon 6. Expression of mutant CHMP2B protein in cells resulted in aberrant structures dispersed throughout the cytosol and the ectopic expression of CHMP2BIntron5 in cortical neurons caused dendritic retraction prior to neurodegeneration.

Sequence analysis of the entire coding region and intron/exon boundaries of CHMP2B from 433 ALS cases identified point mutations in four cases (0.9%)
Miss-sense variants only identified. The phenotype appears to represent a lower motor neuron variant in these cases, however, the present study has not been able to document the segregation of CHMP2B in multiple affected members of specific pedigrees in ALS. CMMP2B may act as a modifier.
Created: 9 Jun 2016, 8:15 a.m.

Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted

Phenotypes
Amyotrophic Lateral Sclerosis, Frontotemporal Dementia

Publications

Mode of pathogenicity
Other

Details

Mode of Inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Sources
  • Expert Review Red
  • Radboud University Medical Center, Nijmegen
Phenotypes
  • Dementia, familial, nonspecific, 600795
  • Amyotrophic lateral sclerosis 17, 614696
OMIM
609512
Clinvar variants
Variants in CHMP2B
Penetrance
Complete
Publications
  • PMID: 20352044 - "We conclude that in a population drawn from North of England pathogenic CHMP2B mutations are found in approximately 1% of cases of ALS and 10% of those with lower motor neuron predominant ALS. We provide a body of evidence indicating the likely pathogenicity of the reported gene alterations. However, absolute confirmation of pathogenicity requires further evidence, including documentation of familial transmission in ALS pedigrees which might be most fruitfully explored in cases with a LMN predominant phenotype."
Mode of Pathogenicity
Other - please provide details in the comments
Panels with this gene

History Filter Activity

19 Dec 2016, Gel status: 1

panel promoted to version 1

Alice Gardham (Genomics England)

Promoted to version 1 on 19th December 2016 following external review and internal curation

15 Jun 2016, Gel status: 1

Gene classified by Genomics England curator

Ellen McDonagh (Genomics England Curator)

This gene has been classified as Red List (Low Evidence).

15 Jun 2016, Gel status: 1

Gene classified by Genomics England curator

Ellen McDonagh (Genomics England Curator)

This gene has been classified as Red List (Low Evidence).

15 Jun 2016, Gel status: 1

Set publications

Ellen McDonagh (Genomics England Curator)

Publications for CHMP2B were set to PMID: 20352044 - "We conclude that in a population drawn from North of England pathogenic CHMP2B mutations are found in approximately 1% of cases of ALS and 10% of those with lower motor neuron predominant ALS. We provide a body of evidence indicating the likely pathogenicity of the reported gene alterations. However, absolute confirmation of pathogenicity requires further evidence, including documentation of familial transmission in ALS pedigrees which might be most fruitfully explored in cases with a LMN predominant phenotype."

15 Jun 2016, Gel status: 1

Set publications

Ellen McDonagh (Genomics England Curator)

Publications for CHMP2B were set to 20352044

15 Jun 2016, Gel status: 1

Set mode of pathogenicity

Ellen McDonagh (Genomics England Curator)

Mode of pathogenicity for CHMP2B was changed to Other - please provide details in the comments

15 Jun 2016, Gel status: 1

Set Mode of Inheritance

Ellen McDonagh (Genomics England Curator)

Mode of inheritance for CHMP2B was changed to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted

18 Aug 2015, Gel status: 1

Added New Source

Ellen McDonagh (Genomics England Curator)

CHMP2B was added to Amyotrophic lateral sclerosis/motor neuron diseasepanel. Source: Radboud University Medical Center, Nijmegen

18 Aug 2015, Gel status: 1

Added New Source

Ellen McDonagh (Genomics England Curator)

CHMP2B was added to Amyotrophic lateral sclerosis/motor neuron diseasepanel. Sources: Radboud University Medical Center, Nijmegen